Mucosal immunization with an attenuated Salmonella vaccine partially protects white-tailed deer from chronic wasting disease

Vaccine

Volumn 33, Issue 5, 2015, Pages 726-733

  Goñi, Fernando ^a   Mathiason, Candace K ^b   Yim, Lucia ^c   Wong, Kinlung ^a   Hayes Klug, Jeanette ^b   Nalls, Amy ^b   Peyser, Daniel ^a   Estevez, Veronica ^c   Denkers, Nathaniel ^b   Xu, Jinfeng ^a   Osborn, David A ^e   Miller, Karl V ^e   Warren, Robert J ^e   Brown, David R ^d   Chabalgoity, Jose A ^c   Hoover, Edward A ^b   Wisniewski, Thomas ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Veterinary Dentistry and Oral Surgery   (United States)

^c Universidad de la Republica Instituto de Higiene   (Uruguay)

^d University of Bath   (United Kingdom)

^e UNIVERSITY OF GEORGIA   (United States)

Author keywords

Bovine spongiform encephalopathy; Chronic wasting disease; Immunization; Mucosal vaccination; Prion protein; Salmonella vaccine strain; White tailed deer

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PRION PROTEIN; SALMONELLOSIS VACCINE; LIVE VACCINE; PRION; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CHRONIC WASTING DISEASE; CONTROLLED STUDY; IMMUNIZATION; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RECTUM MUCOSA; SURVIVAL TIME; TONSIL; WESTERN BLOTTING; WHITE TAILED DEER; ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD; DEER; GENETICS; IMMUNOLOGY; MUCOSAL DRUG ADMINISTRATION; PRION; SALIVA; WASTING DISEASE, CHRONIC;

ADMINISTRATION, MUCOSAL; ANIMALS; BLOOD; DEER; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PRIONS; SALIVA; SALMONELLA VACCINES; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; WASTING DISEASE, CHRONIC;

EID: 84921318133     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.11.035     Document Type: Article

References (51)

1. Colby D.W., Prusiner S.B. Prions. Cold Spring Harb Perspect Biol 2011, 3(January (1)):a006833.
2. Harman J.L., Silva C.J. Bovine spongiform encephalopathy. J Am Vet Med Assoc 2009, 234(January (1)):59-72.
3. Williams E.S. Chronic wasting disease. Vet Pathol 2005, 42(September (5)):530-549.
4. Saunders S.E., Bartelt-Hunt S.L., Bartz J.C. Occurrence, transmission, and zoonotic potential of chronic wasting disease. Emerg Infect Dis 2012, 18(March (3)):369-376.
5. Mitchell G.B., Sigurdson C.J., O'Rourke K.I., Algire J., Harrington N.P., Walther I., et al. Experimental oral transmission of chronic wasting disease to reindeer (Rangifer tarandus tarandus). PLoS ONE 2012, 7(6):e39055.
6. Williams E.S., Young S. Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildl Dis 1980, 16(January (1)):89-98.
7. Williams E.S., Young S. Spongiform encephalopathy of Rocky Mountain elk. J Wildl Dis 1982, 18(October (4)):465-471.
8. Gilch S., Chitoor N., Taguchi Y., Stuart M., Jewell J.E., Schatzl H.M. Chronic wasting disease. Top Curr Chem 2011, 305:51-77.
9. Beekes M., McBride P.A. The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies. FEBS J 2007, 274(February (3)):588-605.
10. Safar J.G., Lessard P., Tamguney G., Freyman Y., Deering C., Letessier F., et al. Transmission and detection of prions in feces. J Infect Dis 2008, 198(July (1)):81-89.
11. Denkers N.D., Hayes-Klug J., Anderson K.R., Seelig D.M., Haley N.J., Dahmes S.J., et al. Aerosol transmission of chronic wasting disease in white-tailed deer. J Virol 2013, 87(February (3)):1890-1892.
12. Marsh R.F., Kincaid A.E., Bessen R.A., Bartz J.C. Interspecies transmission of chronic wasting disease prions to squirrel monkeys (Saimiri sciureus). J Virol 2005, 79(November (21)):13794-13796.
13. Race B., Meade-White K.D., Miller M.W., Barbian K.D., Rubenstein R., LaFauci G., et al. Susceptibilities of nonhuman primates to chronic wasting disease. Emerg Infect Dis 2009, 15(September (9)):1366-1376.
14. Wisniewski T., Goni F. Could immunomodulation be used to prevent prion diseases?. Expert Rev Anti Infect Ther 2012, 10(March (3)):307-317.
15. Goni F., Knudsen E.L., Schreiber F., Scholtzova H., Pankiewicz J., Carp R.I., et al. Mucosal vaccination delays or prevents prion infection via an oral route. Neuroscience 2005, 133:413-421.
16. Hegazy W.A., Hensel M. Salmonella enterica as a vaccine carrier. Future Microbiol 2012, 7(January (1)):111-127.
17. Chabalgoity J.A., Moreno M., Carol H., Dougan G., Hormaeche C.E. A dog-adapted Salmonella Typhimurium strain as a basis for a live oral Echinococcus granulosus vaccine. Vaccine 2000, 19:460-469.
18. Goni F., Prelli F., Schreiber F., Scholtzova H., Chung E., Kascsak R., et al. High titers of mucosal and systemic anti-PrP antibodies abrogates oral prion infection in mucosal vaccinated mice. Neuroscience 2008, 153:679-686.
19. Chabalgoity J.A., Khan C.M., Nash A.A., Hormaeche C.E. A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Mol Microbiol 1996, 19(February (4)):791-801.
20. Goni F., Herline K., Peyser D., Wong K., Ji Y., Sun Y., et al. Immunomodulation targeting both Aβ and tau pathological conformers ameliorates Alzheimer's disease pathology in TgSwDI and 3xTg mouse models. J Neuroinflamm 2013, 10(1):150.
21. Johnson C.J., Herbst A., Duque-Velasquez C., Vanderloo J.P., Bochsler P., Chappell R., McKenzie D. Prion protein polymorphisms affect chronic wasting disease progression. PLoS ONE 2011, 6(3):e17450.
22. Robinson S.J., Samuel M.D., O'Rourke K.I., Johnson C.J. The role of genetics in chronic wasting disease of North American cervids. Prion 2012, 6(April (2)):153-162.
23. Goni F., Prelli F., Ji Y., Scholtzova H., Yang J., Sun Y., et al. Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease. PLoS ONE 2010, 5(10):e13391.
24. Denkers N.D., Telling G.C., Hoover E.A. Minor oral lesions facilitate transmission of chronic wasting disease. J Virol 2011, 85(February (3)):1396-1399.
25. Angers R.C., Kang H.E., Napier D., Browning S., Seward T., Mathiason C., et al. Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science 2010, 328(May (5982)):1154-1158.
26. Sigurdson C.J., Williams E.S., Miller M.W., Spraker T.R., O'Rourke K.I., Hoover E.A. Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). J Gen Virol 1999, 80(October (Pt 10)):2757-2764.
27. Seelig D.M., Mason G.L., Telling G.C., Hoover E.A. Chronic wasting disease prion trafficking via the autonomic nervous system. Am J Pathol 2011, 179(September (3)):1319-1328.
28. Denkers N.D., Seelig D.M., Telling G.C., Hoover E.A. Aerosol and nasal transmission of chronic wasting disease in cervidized mice. J Gen Virol 2010, 91(June (Pt 6)):1651-1658.
29. Pilon J.L., Rhyan J.C., Wolfe L.L., Davis T.R., McCollum M.P., O'Rourke K.I., et al. Immunization with a synthetic peptide vaccine fails to protect mule deer (Odocoileus hemionus) from chronic wasting disease. J Wildl Dis 2013, 49(July (3)):694-698.
30. Delrieu J., Ousset P.J., Caillaud C., Vellas B. 'Clinical trials in Alzheimer's disease': immunotherapy approaches. J Neurochem 2012, 120(January (Suppl 1)):186-193.
31. Wisniewski T. Active immunotherapy for Alzheimer's disease. Lancet Neurol 2012, 11(June (7)):571-572.
32. Wisniewski T., Goni F. Immunotherapy for Alzheimer's disease. Biochem Pharmacol 2014, 88:499-507.
33. Boutajangout A., Wisniewski T. Tau-based therapeutic approaches for Alzheimer's Disease - a mini-review. Gerontology 2014, 60:381-385.
34. Heppner F.L., Christ A.D., Klein M.A., Prinz M., Fried M., Kraehenbuhl J.P., Aguzzi A. Transepithelial prion transport by M cells. Nat Med 2001, 7(September (9)):976-977.
35. Mabbott N.A., MacPherson G.G. Prions and their lethal journey to the brain. Nat Rev Microbiol 2006, 4(March (3)):201-211.
36. Sigurdsson E.M., Wisniewski T. Promising developments in prion immunotherapy. Exp Rev Vac 2005, 4:607-610.
37. Donaldson D.S., Kobayashi A., Ohno H., Yagita H., Williams I.R., Mabbott N.A. M cell-depletion blocks oral prion disease pathogenesis. Mucosal Immunol 2012, 5(March (2)):216-225.
38. Mastroeni P., Chabalgoity J.A., Dunstan S.J., Maskell D.J., Dougan G. Salmonella: immune responses and vaccines. Vet J 2001, 161(March (2)):132-164.
39. Tacket C.O., Sztein M.B., Wasserman S.S., Losonsky G., Kotloff K.L., Wyant T.L., et al. Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect Immun 2000, 68(March (3)):1196-1201.
40. Kirkpatrick B.D., McKenzie R., O'Neill J.P., Larsson C.J., Bourgeois A.L., Shimko J., et al. Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers. Vaccine 2006, 24(January (2)):116-123.
41. Aschfalk A., Muller W. Differences in the seroprevalence of Salmonella spp. in free-ranging and corralled semi-domesticated reindeer (Rangifer tarandus tarandus) in Finland. Dtsch Tierarztl Wochenschr 2003, 110(December (12)):498-502.
42. Lillehaug A., Bergsjo B., Schau J., Bruheim T., Vikoren T., Handeland K. Campylobacter spp., Salmonella spp., verocytotoxic Escherichia coli, and antibiotic resistance in indicator organisms in wild cervids. Acta Vet Scand 2005, 46(1-2):23-32.
43. Gilch S., Wopfner F., Renner-Muller I., Kremmer E., Bauer C., Wolf E., et al. Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells. J Biol Chem 2003, 278(May (20)):18524-18531.
44. Nikles D., Bach P., Boller K., Merten C.A., Montrasio F., Heppner F.L., et al. Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP. J Virol 2005, 79(April (7)):4033-4042.
45. Pilon J., Loiacono C., Okeson D., Lund S., Vercauteren K., Rhyan J., Miller L. Anti-prion activity generated by a novel vaccine formulation. Neurosci Lett 2007, 429(December (2-3)):161-164.
46. Arbel M., Lavie V., Solomon B. Generation of antibodies against prion protein in wild-type mice via helix 1 peptide immunization. J Neuroimmunol 2003, 144(November (1-2)):38-45.
47. Handisurya A., Gilch S., Winter D., Shafti-Keramat S., Maurer D., Schatzl H.M., Kirnbauer R. Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells. FEBS J 2007, 274(April (7)):1747-1758.
48. Ishibashi D., Yamanaka H., Yamaguchi N., Yoshikawa D., Nakamura R., Okimura N., et al. Immunization with recombinant bovine but not mouse prion protein delays the onset of disease in mice inoculated with a mouse-adapted prion. Vaccine 2007, 25(January (6)):985-992.
49. Mathiason C.K., Powers J.G., Dahmes S.J., Osborn D.A., Miller K.V., Warren R.J., et al. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 2006, 314(October (5796)):133-136.
50. Sorensen A., van Beest F.M., Brook R.K. Impacts of wildlife baiting and supplemental feeding on infectious disease transmission risk: a synthesis of knowledge. Prev Vet Med 2014, 113(March (4)):356-363.
51. Muller K., Aabo S., Birk T., Mordhorst H., Bjarnadottir B., Agerso Y. Survival and growth of epidemically successful and nonsuccessful Salmonella enterica clones after freezing and dehydration. J Food Prot 2012, 75(March (3)):456-464.